Printer Friendly



Intramuscular (IM) injections represent the parenteral application of medication through the skin and subcutaneous tissue into the big muscles of the body by means of the appropriate syringe and needle for prophylactic (vaccinations) and therapeutic purposes (antibiotics and hormones) [1]. Until the late 1960s this procedure was done exclusively by physicians when antibiotic therapy was being administered; however, it has become a common practice for nurses since then [2]. According to the estimations of the World Health Organization (WHO) around 12 billion injections are given annually, and about 50% are not preformed safely and present a health risk [1, 2].

Until recently the application of IM injections was mostly based on the theoretical and practical knowledge of nurses gained during their formal clinical education and their personal preferences and habits. Today the applications of intramuscular injections have to be in line with the current best practice guidelines, which are periodically revised according to the existing evidence obtained by studies [1, 3, 4].

To perform IM injections adequately and safely it is necessary to select a sterile needle of the correct length, so the tip of the needle can reach the deep muscles. The needle length depends on the application site, amount of medicine given, patients' age, body weight, muscle mass and the thickness of the subcutaneous fatty tissue at the application site [5-7]. The most commonly used needles for most adults are 21G (green) or 23G (blue), the length of the needle being from 3 to 5 centimeters. It is recommended to use two needles to give an injection, where one is used during the preparation of the medicine and the second one for the application. The changing of the needle reduces pain, and should prevent unwanted complications [7].

The current literature mentions five muscles as potential sites for IM injections: m. gluteus maximus (its dorsal side (DG)), m. gluteus medius ventrogluteal side (VG)), m. vastus lateralis, m. rectus femoris and m. deltoideus [8]. According to the most recent studies and literature the recommended site for the application of IM injections for adults and children older than 7 months is the ventrogluteal site [1-3, 7, 9]. For infants below 7 months of age the recommended site for IM injections is the m. vastus lateralis because it is well developed after birth [7, 9].

Every site recommended for IM injections is rich in nerves and blood vessel, but only the ventrogluteal site does not contain large blood vessels and big nerves, it is far away from bone structures, it has a large muscle surface, the chances of injecting the medicine into the subcutaneous tissue are low and the site can be easily anatomically determined [1, 2]. The results of conducted studies show that injections into the ventrogluteal site are the least painful and there is almost no bleeding. Compared to the dorsogluteal site, the positioning of the patient is easier, and the risk of contamination with feces and urine is lower [2, 10].

The ventrogluteal site can be located by using either V or G method. If the injection is to be administered to the left side by using V method, the nurse positions her right wrist parallel to the patient's left femur and places the palm of her right hand over the patient's greater trochanter and spreads the index and middle finger. The index finger is pointing to the anterosuperior iliac spine, the middle finger is then pointed toward the iliac crest. The index and middle fingers create a V-shape, and the injection site is the middle of the V-shape. If the injection is given on the patient's rightside, nurses use their left hand and vice versa [2, 7].

The Geometric method (G method) to determine the VG site was proposed by Meneses [12], who claimed that its reliability was 100%. To determine the puncture point when using the G method, the bony prominences and imaginary lines are drawn in between them to be used as orientation points. The first imaginary line is drawn from the greater trochanter to the iliac crest, then the second one from the iliac crest to the anterosuperior iliac spine, and the third line from the greater trochanter to the anterosuperior iliac spine. Thus, a triangle is created by imaginary lines. After that, the median lines are drawn for every single corner of triangle. The convergence point of the three median lines is the needle entry point for the injection [2, 11, 12].

The site for the application of IM injections which nurses use most often is the dorsogluteal site also known as m. gluteus maximus [13]. When administering medicine into this muscle there is a great chance of unwanted complications such as: hematoma, abscess, muscle fibrosis, injury of the gluteal artery or the sciatic nerve [2, 5, 13]. None of the sites used for IM injections are 100% safe and without the risk of injury, but the dorsogluteal site is the most disadvantageous [13].

Although the ventrogluteal site has been the recommended site for the administration of IM injection because of its many advantages, very few nurses use it, and the most common reasons for avoiding this site the nurses have mentioned are that the site is anatomically too small, it is hard to locate, they are afraid they might hurt the patient, or they are not accustomed to using this site as well as the lack of training after completing their formal education [2, 13]. The inconsistent information given in the textbooks which are used during the education of nurses is also a contributing factor. The dorsogluteal site is mentioned as a favourable injection site in almost every textbook. However, the VG site has been recommended for the application of IM injections in the Fundamentals of Nursing textbook since the seventh edition published in 2010 while the dorsogluteal site and m. rectus femoris are not mentioned et al. [7].

Therefore, the aims of this study were to evaluate the frequency of using the ventrogluteal site for intramuscular injections in the everyday clinical practice of nurses and to evaluate the nurses' level of knowledge about giving intramuscular injections at the ventrogluteal site.

Material and Methods

The study was conducted in November and December, 2017 as an observational, analytical cross-sectional study, and included nurses from two healthcare institutions, one of the primary level and the other one of the secondary level. The sample size was N = 96 nurses (n = 20 nurses from the primary level and n = 76 nurses from the secondary level institution).

Study Instruments

The questionnaire on the level of knowledge concerning the Ventrogluteal Site for Intramuscular Injection by Gulnar and Caliskan was used as the study instrument [13]. The questionnaire consisted of 22 items on administering injections in the ventrogluteal site, and the nurses could answer with one of three given choices (true, false, don't know). Eleven items were true, and eleven items were false. The reliability of the questionnaire was confirmed with Cronbach's alpha coefficient (a) which in Sari and colleagues' study was 0.84 [2]. In this study after translation and cultural adaptation a was equal to 0.90.

The authors also used a questionnaire for nurses to gather information about the most frequently used injection site for intramuscular injections, to identify the frequency of use of the ventrogluteal site, to determine the level of knowledge about recommendations from contemporary nursing literature and a questionnaire to gather sociodemographic data (sex, age, length of work experience expressed in years, educational level).

Statistical Data Analysis

Descriptive statistics were used to determine the average values, standard deviations (SD), minimal (Min) and maximal (Max) values, 95% confidence interval that is the absolute frequency of occurrences with corresponding percentages depending on the nature of the variable. The normalness of the distribution of data was confirmed with the Kolmogorov Smirnov test (p>0,05). The comparison of the average values from two different groups was done with the t-test, and ANOVA was used to compare average values of multiple groups. Statistical analysis of the results was accomplished with the statistical package IBM SPSS 23 Statistics, and statistical significance was determined at p < 0.05.


Most of the nurses participating in the study were female (91.7%) and high school graduates (94.8%) (Table 1).

The nurses' average age was 37.3 (SD = 10.7). The youngest nurse was 19 years old, while the oldest one was 59 years of age. The average length of work experience was 16.7 (SD = 10.6) years, ranging from minimum 1 and a maximum 38 years.

Over half (n = 63; 65.6%) of nurses thought that according to current literature the dorsogluteal site is the best for giving IM in injections and most of them (85.4%) use it in their daily clinical practice. Only 28.1% of the nurses knew that the ventrogluteal site or m. gluteus medius was the recommended site for IM injections, and only n = 20 nurses (20.8%) used it in their clinical practice. Being not accustomed to using the VG site was the reason why 51.7% of nurses did not use it and 32.6% of nurses said that they were not sufficiently informed about the VG site (Table 2).

The mean score of knowledge of all nurses about intramuscular injection into ventrogluteal site was 8.8 [+ or -] 4.1 out of maximum 22 (the lowest score was 0, and the highest 17).

The average score on the knowledge questionnaire revealed that the lowest percentage of correct answers was given to the items related to the technique of giving an intramuscular injection (items number 19 and number 22). Although almost all of the nurses (94.8%) knew that after entering the tissue, and before injecting the medicine, the presence of blood is checked with aspiration, only 16.7% knew that after the application of the medicine the site should not be massaged. The correct answers for the items regarding the theoretical knowledge about the application of injections into the VG site were under 50% (Table 3).

Although there was a difference in the average score on the knowledge questionnaire about IM injections into the VG site among the nurses when their sociodemographic characteristics were analyzed, it was not statistically significant (Table 4).


According to the most recent literature the ventrogluteal site is recommended as the safest site for the application of intramuscular injections [1-3, 5-8, 14]. In every healthcare system the best quality service and maximal safeness of the patients is the priority. The aim of this study was to examine the frequency of using ventrogluteal site for intramuscular injections and the nurses' level of knowledge on giving intramuscular injections at the ventrogluteal site.

The results of our study show that only 28.1% of nurses are informed that the most recent studies have recommended the ventrogluteal site for intramuscular injections and only 20.8% of them have used this site during their clinical practice. The most commonly used injection site by the nurses who participated in this study was the dorsogluteal site (65.5%). The authors of a study conducted in Turkey have concluded that the number of nurses using the ventrogluteal site for intramuscular injections is low [2]. Similar results have been found in studies conducted in Australia, Ireland and Jordan [3, 14, 15].

Although 70.8% of nurses know that the ventrogluteal site is safe, because it is far from big blood vessels and nerves, most of them still use the dorsogluteal site as their primary choice for the application of intramuscular injections. The dorsogluteal site is thought to be the site with the highest risk of complications when administering an intramuscular injection because it is rich in blood vessels; it is close to the sciatic nerve and the subcutaneous tissue layer is thicker. Sciatic nerve injuries most commonly occur during intramuscular injections at the dorsogluteal site [5, 13]. It has been estimated that 86% of cases of sciatic nerve injuries occur while the injection is being given [13]. The sciatic nerve is the most commonly hit nerve, especially in children, older patients and thin patients. Also, the absorption of medicine is much slower after DG application, because of the thicker layers of fatty tissue [10, 14].

As the most common reason for not using the ventrogluteal site when applying medicine intramuscularly, nurses said that they were not accustomed to using that site (51.7%). These results are comparable with the results of a study conducted with nurses in Turkey. They have also said that the most common reason for not using the ventrogluteal site is that they are not accustomed to using that site [2]. These results reveal a strongly rooted traditional approach to clinical practice, and IM injection skills are passed down from generation to generation [1, 4].

Insufficient knowledge on how to administer IM injection into the VG site was stated by 32.6% of the nurses as the second most common reason for avoiding the ventrogluteal site. The reason for insufficient knowledge may be the fact that even though nurses were taught how to use this site during their education they have never seen it in practice [11]. The teacher themselves are often not confident in their skills of giving IM injections into the VG site and cannot influence their students to opt for this site of administering IM injections [14].

In the knowledge questionnaire used in this study the percentage of correct answers was low for the items related to the location and finding of the ventrogluteal site. According to some studies done in Turkey and Ireland nurses have similar problems and find it hard to locate correctly the puncture site for IM injections at the VG site [2, 11, 14].

The average score on the knowledge questionnaire was 8.8, the maximum being 22. Such a low score confirms that the knowledge of this procedure is insufficient. The percentage of correct answers to some individual statements regarding the technique of intramuscular injections was satisfactory, but the percentage of correct answers regarding the statements about theoretical knowledge of administering IM injections at the VG site was under 50%. Although in the study of Sari and his colleagues the nurses had a higher average score on the knowledge questionnaire ([bar.X] = 14.4) [2], our results are comparable. However, unlike the nurses in Serbia, a high percentage of Turkish nurses (77.6%) knew that the application site should not be massaged after the injection [2]. Massaging of the application site after the application of IM injections was once recommended with the explanation that it would make the absorption of medicine faster and prevent the reaction of local tissues. However, massaging is not recommended anymore because it causes the irritation of the tissue [1, 7].


Based on the results obtained in this study it can be concluded that nurses do not have sufficient knowledge regarding individual elements of the application of intramuscular injections into the ventrogluteal site, such as locating the injection site by using V or G method. Besides, the generally low score achieved on the knowledge questionnaire reveals that the method used by nurses for the application of intramuscular injections lags behind the corpus of current theoretical knowledge.

However, the quality of care and treatment of patients could be improved with the implementation of appropriate additional educational program, which is mandatory for healthcare workers and with the creation of good clinical practice guidelines for IM injections.


[1.] Sakic B, Milutinovic D, Simin D. An assessment of intramuscular injection practices among nursing students and nurses in hospital settings: is it evidence-based? South Eastern Europe Health Sciences Journal. 2012;2(2):114-21.

[2.] Sari D, Sahin M, Yasar E, Taskiran N, Telli S. Investigation of Turkish nurses frequency and knowledge of administration of intramuscular injections to the ventrogluteal site: results from questionnaires. Nurs Educ Today. 2017;56:47-51.

[3.] Wynaden D, Tohotoa J, AL Omari O, Happell B, Heslop K, Barr L, et al. Administering intramuscular injections: How does research translate into practice over time in the mental health setting? Nurse Educ Today. 2015;35(4):620-4.

[4.] Greenway K. Rituals in nursing: intramuscular injections. J Clin Nurs. 2014;23(23-24):3583-8.

[5.] Kaya N, Salmaslioglu A, Terzi B, Turan N, Acunas B. The reliability of site determination methods in ventrogluteal area injection: a cross-sectional study. Int J Nurs Stud. 2015;52(1):355-60.

[6.] Hunt CW. Which site is best for an I.M. injection? Nursing. 2008;38(11):62.

[7.] Taylor CR, Lillis C, LeMone P, Lynn P. Fundamentals of nursing: the art and science of nursing care. 7th ed. Philadelphia: Wolters Kluwer Health / Lippincott Williams & Wilkins; 2011.

[8.] Malkin B. Are techniques used for intramuscular injection based on research evidence? Nurs Times. 2008;104(50-51):48-51.

[9.] Aschenbrenner D, Venable S. Drug therapy in nursing. 3rd ed. Philadelphia: Wolters Kluwer Health / Lippincott Williams & Wilkins; 2009.

[10.] Larkin TA, Ashcroft E, Elgellaie A, Hickey BA. Ventrogluteal versus dorsogluteal site selection: a cross-sectional study of muscle and subcutaneous fat thicknesses and an algorithm incorporating demographic and anthropometric data to predict injection outcome. Int J Nurs Stud. 2017;71:1-7.

[11.] Kara D, Uzelli D, Karaman D. Using ventrogluteal site in intramuscular injections is a priority or an alternative? International Journal of Caring Sciences. 2015;8(2):507-13.

[12.] de Meneses AS, Marques IR. A proposal for a geometrical delimitation model for ventro-gluteal injection. Rev Bras Enferm. 2007;60(5):552-8.

[13.] Gulnar E, Ozveren H. An evaluation of the effectiveness of a planned training program for nurses on administering intramuscular injections into the ventrogluteal site. Nurse Educ Today. 2016;36:360-3.

[14.] Cocoman A, Murray J. Recognizing the evidence and changing practice on injection sites. Brit J Nurs. 2010;19(18):1170-4.

[15.] Hdaib MT, Al-Momany SM, Najjar YW. Knowledge level assessment and change among nursing students regarding administering intra-muscular injection at Al-Balqa'a Applied University: an interventional study. Nurse Educ Today. 2015;35(7):e18-22.

Dragana MILUTINOVIC (1), Sanja TOMIC (1), Valentin PUSKAS (2), Branislava BRESTOVACKI SVITLICA (1), Dragana SIMIN (1)

(1) University of Novi Sad, Faculty of Medicine Novi Sad Department of Nursing

(2) Medical Secondary School "7. April", Novi Sad

Corresponding Author: Prof. dr Dragana Milutinovic: Univerzitet u Novom Sadu, Medicinski fakultet, Katedra za zdravstvenu negu, 21000 Novi Sad, Hajduk Veljkova 3, E-mail:

Rad je primljen 3. IX 2018.

Recenziran 5. IX 2018.

Prihvacen za stampu 10. IX 2018.

BIBLID.0025-8105:(2018):Suppl 1:59-64.
Table 1. Distribution of nurses according to sociodemographic
Tabela 1. Distribucija medicinskih sestara u odnosu na sociodemografske

Sociodemographic characteristics of nurses/Sociodemografske   n    %
karakteristike medicinskih sestara

Gender/Pol         Male/Musko                                 8    8.3
                   Female/Zensko                             88   91.7
Total/Ukupno                                                 96  100.0
Educational level  High school/Srednja skola                 91   94.8
Nivo obrazovanja   Associate degree/Visa skola                2    2.1
                   Professional bachelor/Strukovne studije    3    3.1
Total/Ukupno                                                 96  100.0

n - absolute frequency/apsolutna ucestalost, % - relative frequency
/relativna ucestalost

Table 2. The distribution of nurses according to the characteristics of
giving intramuscular injections
Tabela 2. Distribucija medicinskih sestara prema karakteristikama
davanja intramuskularne injekcije

Data on application of intramuscular injections/Podaci o       n     %
primeni intramuskularne injekcije

Most frequently used site  Dorsogluteal site/Dorzoglutealno    82   85.4
/Najcesce korisceno mesto  mesto
                           Ventrogluteal site/Ventroglutealno   8    8.3
                           m. rectus femoris/Misic rectus       6    6.3
Total/Ukupno                                                   96  100.0
Site recommended by the    Dorsogluteal site/Dorzoglutealno    63   65.6
latest literature          mesto
Mesto davanja preporuceno  Deltoid muscle/Deltoidni misic       1    1.0
po savremenoj literaturi   Ventrogluteal site/Ventroglutealno  27   28.1
                           m. rectus femoris/Misic rectus       5    5.2
Total/Ukupno                                                   96  100.0
Have you given injections  Yes/Da                              20   20.8
to the VG site in your
professional life?
Da li u vasem              No/Ne                               76   79.2
profesionalnom radu
dajete IM injekciju u
ventroglutealno mesto?
Total/Ukupno                                                   96  100.0
Reasons for not using      I'm not used to it./Nisam           46   51.7
the VG site (only nurses   naviknut/a na to.
that do not use the VG     I don't have enough information to  29   32.6
site)                      use the VG site./Nemam dovoljno
Razlozi za nekoriscenje    znanja za primenu injekcije na tom
VG mesta                   mestu.
(samo med. sestre koje
ne koriste VG mesto)
                           Other/Drugi razlog                  14   15.7
Total/Ukupno                                                   89  100.0

n - absolute frequency/apsolutna ucestalost, % - relative frequency
/relativna ucestalost

Table 3. Distribution of the responses given by nurses to the knowledge
questionnaire about intramuscular injections into the ventrogluteal site
Tabela 3. Distribucija odgovora medicinskih sestara na upitniku znanja o
intramuskularnoj injekciji u ventroglutealnom mestu

Statement about IM injections into the VG site  Correct answer  n    %
Tvrdnje o IM injekciji u VG mesto               Tacan odgovor

After entering the tissue and before            True/Tacno      91  94.8
administering the medicine, a blood check is
made by drawing back the piston./Posle ulaska
u tkivo, a pre davanja leka proverava se
prisutnost krvi aspiracijom.
The injection site is wiped with an antiseptic  True/Tacno      87  90.6
pad in a circle of 5 cm diameter from the
injection site. Mesto davanja injekcije se
dezinfikuje antiseptikom u krugu sa dijametrom
od 5 cm oko ulaznog mesta igle.
The injection is given after the antiseptic     True/Tacno      79  82.3
solution has dried.
Injekcija se daje kada se antiseptik osusio.
Injection at the VG site is safe because it is  True/Tacno      68  70.8
far from large blood vessels and nerves.
/Davanje injekcije na VG mestu je bezbedno
zato sto je daleko od velikih krvnih sudova i
To establish the injection site, the nurse      True/Tacno      53  55.2
places the lower part of the palm of her hand
on the greater trochanter of the femur./Da bi
se odredilo mesto injekcije medicinska sestra
postavlja dlan sake na veliki trohanter
After the injection, the injection site is      False/Netacno   16  16.7
massaged./Posle davanja injekcije mesto
davanja se masira.
Injection to the VG site may be difficult in    True/Tacno      41  42.7
very overweight patients because the greater
trochanter cannot be found./Davanje injekcije
na VG mestu moze biti otezano kod jako
gojaznih pacijenata zato sto se ne moze
pronaci veliki trohanter femura.
For injection to the VG site, the patient may   True/Tacno      40  41.7
be lain on the back, prone, or on the side. Za
davanje injekcije na VG mestu pacijent moze da
lezi na ledima, na stomaku i/ili na boku.
The risk of contamination of the VG site with   False/Netacno   65  67.7
feces is high. Rizik od kontaminacije VG mesta
fecesom je veliki.
High volume muscles such as the VG site can     True/Tacno      29  30.2
take up to 4 ml of medicine./Misici velike
zapremine, kao onaj u VG mestu mogu primiti do
4 ml leka.
In the VG site, it is difficult for the needle  False/Netacno   22  22.9
to reach the muscle because of the thickness
of the subcutaneous fatty layer./Kod davanja
injekcije u VG mesto, igla tesko dolazi do
misicne mase zbog velike debljine supkutanog
masnog tkiva.
The commonest complication in the VG area is    False/Netacno   40  41.7
damage to the sciatic nerve./Najcesca
komplikacija kod davanja injekcije u VG mesto
je ostecenje ishijadicnog nerva.
At the VG site, injection-related               True/Tacno      35  36.5
complications such as fibrosis, nerve damage,
abscesses, tissue necrosis and pain do not
occur./Kod davanja injekcije u VG mesto
komplikacije kao sto su: fibroza, povreda
nerva, apscesi, nekroza tkiva i bol se ne
Patients are recommended to exercise the leg    True/Tacno       8   8.3
after the injection.
Pacijentima je preporuceno da rade vezbe posle
davanja injekcije u VG mesto.
Use of the VG muscle is recommended in          True/Tacno      16  16.7
children of over 7 months because it is well
developed./Primena injekcije u VG mesto se
preporucuje kod dece starije od 7 meseci.
Medication is injected quickly in a few         False/Netacno   39  40.6
Prilikom davanja injekcije lek se ubrizgava
brzo, tokom nekoliko sekundi.
The VG site is not recommended for the          False/Netacno   30  31.3
administration of irritants or oily solutions.
G-mesto se ne preporucuje za davanje
iritantnih lekova i masnih solucija.
In order to determine the injection site, the   False/Netacno   28  29.2
nurse should use her right hand in the
patient's right hip, and her left hand on the
left hip./Za odredivanje VG mesta medicinska
sestra koristi desnu ruku na pacijentovom
desnom kuku, i levu ruku na pacijentovom levom
The VG site is palpated using imaginary lines   False/Netacno    3   3.1
and the DG site by the use of bone structure.
/VG mesto se locira koriscenjem nevidljivih
linija, dok se DG mesto locira palpiranjem
kostanih str.uktura.
The VG site is used only with adults.           False/Netacno   33  34.4
/Injekcija u VG mesto se koristi samo kod
The tissue at the injection site is grasped     False/Netacno   14  14.6
between the thumb and the forefinger.
Tkivo na mestu davanja injekcije prilikom
davanja leka treba obuhvatiti palcem i
The injection site is the area below the iliac  False/Netacno    5   5.2
crest and above an imaginary diagonal line
connecting the posterior superior iliac spine
and the greater trochanter of the femur./Mesto
davanja injekcije je povrsina ispod karlicnog
grebena (spina iliaca) i iznad zamisljene
dijagonalne linije koja povezuje zadnju gornju
ilijacnu bodlju (spina iliaca posterior
superior) i veliki trohanter femura.

Table 4. Total average score on the knowledge questionnaire: differences
regarding the sociodemographic characteristics of the nurses
Tabela 4. Ukupni prosecni skor na upitniku znanja: razlike u odnosu na
sociodemografske karakteristike medicinskih sestara

                      Average [+ or -] SD     t/F          95% CI
                      Prosek [+ or -] SD

Age/Godine zivota
19-30 years (n = 32)  9.5 [+ or -] 3.6                  8.2806-10.8444
31-40 years (n = 34)  8.8 [+ or -] 3.8     1.312 (**)   7.4502-10.1380
> 40 years (n = 30)   7.9 [+ or -] 4.7                  6.1504-9.65922
Place of employment
/Radno mesto
Health Centre/Dom     8.8 [+ or -] 4.9     0.036 (*)   -1.99653-2.07022
zdravlja (n = 20)
Hospital/Bolnica      8.7 [+ or -] 3.8                 -2.40404-2.47773
(n = 76)
Length of work
radnog staza
1-19 years (n = 33)   9.1 [+ or -] 3.6                  7.8113-10.3705
20-30 years (n = 31)  9.2 [+ or -] 3.7     0.874 (**)   7.8543-10.5973
> 30 years (n = 32)   8.0 [+ or -] 4.7                  6.2917-9.7083


Age/Godine zivota
19-30 years (n = 32)
31-40 years (n = 34)  > 0.05
> 40 years (n = 30)
Place of employment
/Radno mesto
Health Centre/Dom     > 0.05
zdravlja (n = 20)
(n = 76)
Length of work
radnog staza
1-19 years (n = 33)
20-30 years (n = 31)  > 0.05
> 30 years (n = 32)

t-test (*); ANOVA (**)
COPYRIGHT 2018 Drustvo Lekara Vojvodine
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2018 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Author:Milutinovic, Dragana; Tomic, Sanja; Puskas, Valentin; Svitlica, Branislava Brestovacki; Simin, Draga
Publication:Medicinski Pregled
Article Type:Report
Date:Aug 15, 2018

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |